Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ELA-026 by Electra Therapeutics for Hemophagocytic Lymphohistiocytosis: Likelihood of Approval
ELA-026 is under clinical development by Electra Therapeutics and currently in Phase I for Hemophagocytic Lymphohistiocytosis. According to GlobalData, Phase...